SmPC - Cabazitaxel Accord 20 mg/ml Concentrate for solution for infusion: Change history
View Summary of Product Characteristics (SmPC - Cabazitaxel Accord 20 mg/ml Concentrate for solution for infusion)
Last updated on this site: 27 Jul 2023
To update sections 4.4, 4.6 and 5.3 of the SmPC in line with the reference product, (JEVTANA 60 mg concentrate and
solvent for solution for infusion; EU procedure reference number with outcome: EMEA/H/C/002018/II/0049; MAH: Sanofi
Winthrop Industrie, France). Consequently, the PIL has been updated.
Last updated on this site: 27 Jul 2023
To update sections 4.4, 4.6 and 5.3 of the SmPC in line with the reference product, (JEVTANA 60 mg concentrate and
solvent for solution for infusion; EU procedure reference number with outcome: EMEA/H/C/002018/II/0049; MAH: Sanofi
Winthrop Industrie, France). Consequently, the PIL has been updated.
-
Changes: (Updated: 27 Jul 2023)
To update sections 4.4, 4.6 and 5.3 of the SmPC in line with the reference product, (JEVTANA 60 mg concentrate and
solvent for solution for infusion; EU procedure reference number with outcome: EMEA/H/C/002018/II/0049; MAH: Sanofi
Winthrop Industrie, France). Consequently, the PIL has been updated.
-
Changes: (Updated: 31 May 2023)
Website update: amended file name. No change to document.
-
Changes: (Updated: 31 May 2023)
Website update: amended file name. No change to document.
-
Changes: (Updated: 20 Sep 2022)
Initial upload